PE/TR Anti-Human CD134 Antibody[ Ber-ACT35]

Introducing the PE/TR Anti-Human CD134 Antibody [BER-ACT35], a cutting-edge product designed to facilitate advanced research in the field of immunology. This antibody, meticulously developed by our team of experts, exhibits exceptional specificity and sensitivity, making it an invaluable tool for the detection and analysis of CD134 expression in human samples.

The PE/TR Anti-Human CD134 Antibody [BER-ACT35] is meticulously engineered to target CD134, a crucial co-stimulatory molecule involved in T-cell activation and immune response regulation. With its high affinity and selectivity, this antibody enables precise identification and characterization of CD134-positive cells, aiding in the understanding of immune system dynamics and the development of novel therapeutic strategies.

This product is formulated with the utmost care, ensuring optimal performance and reproducibility in a variety of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its exceptional performance is further enhanced by the conjugation of two fluorochromes, PE and TR, enabling simultaneous detection of CD134 expression alongside other markers of interest.

The PE/TR Anti-Human CD134 Antibody [BER-ACT35] is rigorously tested to meet the highest quality standards, guaranteeing reliable and consistent results. Its exceptional specificity minimizes non-specific binding, reducing background noise and enhancing data accuracy. Additionally, this antibody exhibits excellent stability, ensuring long-term storage without compromising its performance.

In summary, the PE/TR Anti-Human CD134 Antibody [BER-ACT35] is an indispensable tool for researchers seeking to unravel the intricacies of CD134-mediated immune responses. With its exceptional specificity, sensitivity, and versatility, this antibody empowers scientists to delve deeper into the complexities of immunology, paving the way for groundbreaking discoveries and advancements in the field.